StockNews.com initiated coverage on shares of Athersys (NASDAQ:ATHX – Get Free Report) in a research note issued on Thursday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock.
Athersys Stock Performance
Athersys has a 1 year low of $0.01 and a 1 year high of $1.99. The company has a market cap of $833,000.00, a P/E ratio of -0.01 and a beta of -0.90.
Athersys Company Profile
Further Reading
- Five stocks we like better than Athersys
- Consumer Discretionary Stocks Explained
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- How Investors Can Find the Best Cheap Dividend Stocks
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Manufacturing Stocks Investing
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Athersys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Athersys and related companies with MarketBeat.com's FREE daily email newsletter.
